Hello!

Triptika Studios are producing a pilot for the documentary series about the worldwide re-emergence of the psychedelic movement and the crucial role of psychedelic substances in human culture from prehistory to modern times. The film aims to de-stigmatise psychedelic use by presenting personal and professional accounts of beneficial use from a wide array of individuals. We make a clear call for their responsible therapeutic use, for personal growth and collective healing, including traditional, indigenous applications of plant medicines and substances.

Among many contributors involved in the psychedelic renaissance, we meet Dr Ben Sessa who runs study into MDMA Assisted Psychotherapy for Alcohol Addiction at Bristol University, Dr Rosalind Watts who is a lead clinician in the Psilocybin for Depression study at Imperial College, Chris Timmerman who leads on a study into The Neuroscience of DMT, and Amanda Feilding from the Beckley Foundation who is branded the Countess of Psychedelic Science and seen as the ‘hidden hand’ behind it. The documentary also includes the voices of many people whose lives were improved by psychedelics, including Kevin Matthews from Decriminalize Denver Campaign who decided to campaign for decriminalisation soon after psilocybin mushrooms helped him with his own mental health problems.

We feel strongly that if the public is made aware of the potential of psychedelic and plant medicines for therapeutic use, the demand will facilitate a necessary shift in out-dated drug laws.

Who are we?

We are an intersectional collective of artists, including filmmakers, musicians and entrepreneurs, advocating for the responsible and intentional use of psychedelic substances and plant medicines for personal and collective healing.

team triptika

The film series {UPDATE}

We originally intended this to be a feature-length documentary film project, but we’ve recently realised that with the psychedelic field expanding and amplifying at dizzying speeds, that the exploration of this subject is best suited to a film series. This way, we can continue to discover and capture various aspects of this movement as they happen, while releasing relevant and captivating episodes as we go!

We will continue to explore all relevant and current aspects of the field of psychedelics, including but not limited to; medical and clinical research, neuroscience, neuropsychology, clinical psychology and psychotherapy, spirituality, philosophy, recreation, art, music, cyberdelics (Psychedelic Virtual Reality), XR (Extended Reality) and the crypto-psychedelic movement. The series delves into global, historical and traditional psychedelic use, their socio-cultural value, their value in environmental justice movements, and finally, their potential for healing, curing and alleviating a vast number of conditions that plague modern society, including depression, PTSD and substance-use disorder among many others.

We feel it is vital to present a wide diversity of perspectives within the psychedelic movement. We understand that psychedelics and plant medicines are not a magic cure and that they may not serve everyone. We will not shy away from revealing and exploring the shadow-side of psychedelic use, and we intend to do our best to present an unbiased account of the history, current reality, and future trajectories of the movement, through multiple perspectives including BIPOC, and LGBTQI2S+ people.

The mission

Mental health is a defining issue of our generation, with approximately one in every four people suffering from ‘mental illness’. In 2017, The World Health Organization (WHO) began a campaign to prioritise global mental health, stating:

“Behavioral health disorders are on the trajectory to surpass all other diseases as a major cause of disability by 2020. Each year, approximately $2.5 trillion is lost in the global economy to mental illness; this number is expected to increase to $6 trillion in a little over a decade.

We intend to de-stigmatise psychedelic use by presenting personal and professional accounts of beneficial use from a wide array of individuals. We make a clear call for their responsible therapeutic use,  for personal growth and collective healing, including traditional, Indigenous applications of plant medicines and substances.

Watch the trailer

Support us

DETAILS OF FUTURE PRODUCTION COSTS >>>
We seek funding to produce a high-quality pilot for an episodic film series, which will appeal to a broad audience, including those who have never considered psychedelic substances as a legitimate tool for healing and growth. While filming the pilot, we are collecting additional content that will be used in the series.

Project Development >> £400
Salaries >> £7600
Production expenses, mainly equipment >> £2050
Travel & Accommodation { USA, Canada, The Netherlands} >> £2470
Post-Production >> £11100
Administration >> 2950
Loan Repayment >> £8250
Contingency 5% >> £1874

TOTAL: £39354 / 39.5K

Any form of financial support will help us to move the project forward. It will allow us to both continue with the production as well as to create and run a successful fundraising campaign.

17K will allow us to complete filming
29K will allow us to complete filming and to pay for editing
39.5K will allow us to add compelling animation and bespoke sound design

You can donate via

PayPal

or gofundme.com/the-psychedelic-renaissance-documentary

Accessible distribution + public screenings + future plans for release

THE PILOT
We intend to release a pilot episode of ‘The Psychedelic Renaissance’, with free, public screenings set for mid-2020. We have been invited to screen at psychedelic conferences around the world, as well as educational institutions such as Oxford University and Newcastle University. After initial screenings, the pilot will be available for free online and promoted by our community partners such as the Beckley Foundation, MAPS and psychedelic societies around the world, as well as other associated institutions and brands with interest in psychedelics.

In August, we have screened a work-in-progress cut of the film at the 2019 Breaking Convention conference in London, UK. The auditorium was packed with people who received the film enthusiastically and approached us to express their support and gratitude.

THE SERIES
We will continue to work towards providing accessible screening options through educational institutions and partner organisations, with a simultaneous goal of selling the series to public broadcasters. Our goal is still to give the broadest possible access to the film series and the vital knowledge it will hold. In the absence of a traditional distribution deal, we will make the series available on a digital platform.

ADDITIONAL CONTENT
We will maximise our impact by producing additional content that can be used for education and harm reduction. Footage will be developed for online, social media content. We are currently developing a subsequent online series that will focus on women in the psychedelic field.

The impact

Our film series sets out to shift the negative propaganda and stigma around psychedelic substance use while educating the public about the potential personal and collective benefits of these extraordinary allies. We feel strongly that if the public is made aware of the potential of psychedelic and plant medicines for therapeutic use, the demand will facilitate a necessary shift in out-dated drug laws. These laws restrict cognitive liberties and disproportionately criminalise marginalised people in many regions of the world.

Approximately 1 in 4 people in the UK will experience a common mental health problem (such as anxiety and depression) each year, according to the official figures from the mental health charity, Mind. In the United States alone, mental illnesses are affecting approximately 47 mln of people each year, according to The National Institute of Mental Health. One must keep in mind that these numbers account only for reported cases, but in reality, the number of undiagnosed individuals is immeasurable. Mental illness is an imminent global issue which can no longer be ignored. Many people around the world suffer from treatment-resistant conditions that have the potential to be healed with the aid of psychedelic substances.

We have known of the therapeutic qualities of psychedelics since the first studies conducted in the 1950s. In 1951, renowned British psychiatrist Ronald Sandison wrote that LSD gives increased access to repressed experiences, opening childhood memories, and allowing patients to explore traumatic events of their past while providing associated emotional release and healing.

Today, we have the tools in contemporary neurological science, such as neuroimaging, that gives us an opportunity to revisit the studies of the 1950s and 1960s with new eyes, and to research the potential for curing the 21st-century epidemic of mental and emotional suffering.

Pilot episode contributors

We interview some of the leading scientists and clinicians that have contributed to discoveries in psychedelic science, and we interweave these interviews with those whose lives were transformed through psychedelics.

Dr Ben Sessa (Bristol University)
Amanda Feilding (The Beckley Foundation)
David E Nichols
Natalie Ginsberg (MAPS)
Ismail Ali (MAPS)
Nikki Wyrd (Breaking Convention, Psychedelic Press)
Julian Vayne (Psychedelic Press, Breaking Convention)
Chris Timmerman (Imperial College)
Rosalind Watts (Imperial College)
Camille Barton (Artist and Drug Activist)
Mendel Kaelen (Imperial College)
Arno Adelaars (Author and Drug Activist)
Jakobien Van der Weiden (Microdose NL)
Hein Pijnnaken (Microdose NL)
Darren Springer (Mycologist)
Carl H. Smith (Ravensbourne University, Virtual Awakening)
Stephen Reid (The Psychedelic Society UK)
Gaia Harvey-Jackson (The Psychedelic Society UK)
Eva Cesarova (The Psychedelic Society of Czech Republic)
Vincent Veroust (The Psychedelic Society of France)
Jose Montemayor (Virtual Awakening)
and more

Partner organisations

We are lucky to work with and be supported by many organisations, groups and brands such as:

All Logos 4

 

 

Updates